E. Kurt Et Al. , "Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer," TUMORI , vol.92, no.6, pp.481-486, 2006
Kurt, E. Et Al. 2006. Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer. TUMORI , vol.92, no.6 , 481-486.
Kurt, E., Kurt, M., Kanat, O., Cetintas, S., Aygun, S., Palazoglu, J., ... Ozkan, L.(2006). Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer. TUMORI , vol.92, no.6, 481-486.
Kurt, Ender Et Al. "Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer," TUMORI , vol.92, no.6, 481-486, 2006
Kurt, Ender Et Al. "Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer." TUMORI , vol.92, no.6, pp.481-486, 2006
Kurt, E. Et Al. (2006) . "Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer." TUMORI , vol.92, no.6, pp.481-486.
@article{article, author={Ender Kurt Et Al. }, title={Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer}, journal={TUMORI}, year=2006, pages={481-486} }